ArticleNature immunology2020
The coming of age of Langerhans cell histiocytosis.
Article in Nature immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Class 3 MAP2K1 mutations associate with relapse and multiple treatment lines in multisystem Langerhans cell histiocytosis.Blood advances · 2026Article
- Histiocytosis development and clinical variation through the lens of genomics.The Journal of pathology · 2026Review
- No detectable infectious agents in Langerhans cell histiocytosis with lung involvement.ERJ open research · 2026Article
- Blood MMP-7 and TNF-α levels as potential prognostic biomarkers for adult pulmonary Langerhans cell histiocytosis.Scientific reports · 2026Article
- Histiocyte Society blueprint for Langerhans cell histiocytosis research: from cell-of-origin to a more comprehensive cure.Haematologica · 2025Review
- Anxiety and depression in patients with histiocytic neoplasms and their associated clinical features.Blood advances · 2025Observational
- Molecular Mutations in Histiocytosis: A Comprehensive Survey of Genetic Alterations.Molecular biotechnology · 2025Review
- Orbital histiocytosis; From A to Z.International ophthalmology · 2024Review
- Article
- Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis.Blood advances · 2023Article
- Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis.Cancer science · 2023Article
- Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.Blood advances · 2023Article
- Ultrasonographic analysis of Langerhans cell histiocytosis in children: a report of 55 cases.The Journal of international medical research · 2022Article
- Aggressive unifocal bone Langerhans cell histiocytosis with soft tissue extension both responsive to radiotherapy: a case report.Radiation oncology (London, England) · 2022Article
- Multisystem Langerhans Cell Histiocytosis in Younger Infants First Presenting in Skin: A Case Series.Journal of personalized medicine · 2022Article
- Langerhans cell histiocytosis presenting as an isolated brain tumour: A case report.World journal of clinical cases · 2022Article
- Article
- Waxing and Waning Neuroimaging Abnormalities in Langerhans Cell Histiocytosis.Neurology. Clinical practice · 2021Article
- Histiocytosis.Lancet (London, England) · 2021Review
- [Pediatric bone marrow alterations].Der Radiologe · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
31831887What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.